Tags
Blog

'cancer' posts

The Race Continues…19th Annual SummeRun & Walk Raises $558,000 for Ovarian Cancer Research

SEATTLE — August 12, 2013 — More than 3,500 enthusiastic patients, survivors and supporters gathered in Seattle last month to participate in the 19th annual Swedish presents SummeRun & Walk for ovarian cancer. Thanks to energized and proactive participants, this year’s event raised more than $558,000 in support of ovarian cancer research.


The SummeRun & Walk celebrates and remembers the lives of those who have been impacted by ovarian cancer. It is the Northwest’s largest community event to raise awareness and vital funds for ovarian cancer. Since its inception, the SummeRun has raised more than $6 million for medical research into the treatment, early detection, and prevention of this disease.

Swedish Presents SummeRun & Walk for Ovarian Cancer

Although ovarian cancer comprises only 3% of all women’s cancers, it is the fifth leading cause of women’s cancer deaths. Women who are diagnosed with advanced stage ovarian cancer have a long-term survival rate of only 10%.

When detected in its earliest stages, ovarian cancer survival rates can be as high as 90%. However, early stage symptoms are usually difficult to diagnose, are often misdiagnosed, or go undetected, which leads to nearly 75% of all ovarian cancer patients being diagnosed in advanced stages.

Through innovative research and scientific community collaboration, we can work together to reduce and prevent this disease that disproportionately affects women. We are working to support ovarian cancer research in honor of our wives, mothers, sisters, daughters, and friends.

The Marsha Rivkin Center for Ovarian Cancer Research has been working to save lives and reduce suffering through the prevention of ovarian cancer, early detection, and improved treatment. Through community donations, the Marsha Rivkin Center works to advance research related to ovarian cancer nationwide, and improve outcomes for women facing ovarian cancer. The annual SummeRun, presented by Swedish, is a particularly unique community event and fundraising opportunity that supports ovarian cancer research and the Marsha Rivkin Center’s mission.

 

{^youtubevideo|(width)425|(height)264|(url)http://www.youtube.com/watch?v=-twcrOc48dA|(rel)1|(fs)1^}

 


SummeRun 2013 Race Details

Greg Foltz, M.D. – A legacy to remember

SEATTLE, July 3, 2013 – Greg Foltz, M.D., director of the Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment at the Swedish Neuroscience Institute (Ivy Center), passed away from Stage IV pancreatic cancer on Thursday, June 27. Dr. Foltz, who was 50 years old, spent the last 20 years as a pioneer and champion for advancing brain cancer research in the hope of one day finding a cure.

Noninvasive Prostate Cancer Treatment Data is Maturing & Promising

Many of my patients are men seeking prostate cancer treatment they can undergo while continuing work and maintaining active lifestyles. Equally important is the cancer-free survival rate and long-term side effect profile. For over seven years we have been treating men with organ-confined prostate cancer using the CyberKnife® stereotactic radiosurgery system. This sophisticated radiation delivery system uses a robotic arm to deliver precise treatment doses to the prostate in only 5 sessions so the men can keep up their normal routine while combatting their disease.

The data supporting this treatment option continues to grow and a recent study following men for 6 years reports patients had excellent biochemical control rates (based on...

Thrive Through Cancer Presents Chemo-Con at Swedish Cancer Institute

Thrive Through Cancer is a non-profit organization that helps young adults with cancer and their caregivers find hope and thrive. Through support groups, social events and community forums, Thrive Through Cancer aims to engage young adult community members by providing support and resources during their fight against cancer.

On June 20, 2013 Thrive Through Cancer will host a social event for young adults, their families, friends and caregivers at the Swedish Cancer Institute: Chemo-Con!

Come meet Rose Egge, founder of Thrive Through Cancer, and join us for two educational and interactive workshops focused on issues commonly experienced by young adults affected by cancer.

  • Join Registered Dietician Julie Herbst for a conversation about healthy eating, maximizing nutritional intake and managing symptoms with foods. Recipe and sampling provided.
  • Jacci Thompson-Dodd, MA, MSSS will host a discussion about intimacy and cancer, and can help answer any questions you may have. 

You will also have the opportunity to learn more about community partners, resources and services available in areas near you from the following organizations:

Swedish Celebrates Dr. Saul Rivkin’s Long, Impressive Career as a Devoted, Accomplished Medical Oncologist and Researcher in Fight Against Ovarian Cancer



SEATTLE, June 6, 2013 – Swedish Cancer Institute (SCI) announced today that Saul Rivkin, M.D., medical oncologist, as well as founder and board chair of the Marsha Rivkin Center for Ovarian Cancer Research, will retire from his clinical practice at SCI on July 1, 2013. The highly respected and revered physician, who is 77 years old and has five daughters and seven grandchildren, Dr. Rivkin is best known for his committed, tenacious approach to fighting cancer and the personal connection he has established with the thousands of patients he has cared for over the years.

BRCA Genetic Testing for Hereditary Breast and Ovarian Cancer

In today’s New York Times, actress and director Angelina Jolie bravely and openly discusses her experience with BRCA genetic testing for hereditary breast and ovarian cancer:

The 37 year old Ms. Jolie – who has not had cancer – underwent genetic testing because of her family history of cancer. She was found to carry a mutation in the BRCA1 gene, which puts her at significant risk of developing breast and ovarian cancers. Ms. Jolie, the mother of 3 adopted and 3 biological children, elected to undergo a risk-reducing double mastectomy, and plans to have her ovaries and fallopian tubes removed soon to lower her risk of developing ovarian cancer.

Ms. Jolie’s story opens a public conversation about the importance of genetic testing in helping to reduce a woman’s risk of developing breast and ovarian cancers. This very personal decision about mastectomy by someone widely regarded as one of the most beautiful women in the movies also helps women recognize that their body image and sexuality does not have to be defined by their breasts. Not every woman will make the decision to have major surgery, but genetic test results can also make sure that your breast cancer screening is appropriate for your level of risk; women who carry a BRCA gene mutation need ...

Results 57-63 of 100